New hope for bile duct cancer: immunotherapy plus chemotherapy trial launches
Disease control
Not yet recruiting
This phase 2 trial tests whether adding the immunotherapy drug envafolimab to standard chemotherapy (gemcitabine plus cisplatin) helps people with advanced bile duct or gallbladder cancer live longer without their cancer growing. About 126 adults who have not had prior treatment …
Phase: PHASE2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC